Status:
COMPLETED
Sinolpan® Pharmacy Non-interventional Study - Quality of Live
Lead Sponsor:
Engelhard Arzneimittel GmbH & Co.KG
Collaborating Sponsors:
ClinCompetence Cologne GmbH
Conditions:
Rhinosinusitis Acute
Rhinosinusitis Chronic
Eligibility:
All Genders
18+ years
Brief Summary
This non-interventional study investigates the Quality of Life of patients suffering from rhinosinusitis. Patients who seek advice in a pharmacy and choose to intake Sinolpan® or Sinolpan® forte or to...
Detailed Description
Within the scope of this non-interventional observational study, the quality of life of rhinosinusitis patients under self-medication with the 1,8 - cineole preparation Sinolpan® or Sinolpan® forte (S...
Eligibility Criteria
Inclusion
- Suitable patients for the Sinolpan® group are patients aged 18 years or older who seek advice from a pharmacy regarding the treatment of their acute or chronic (rhino) sinusitis and, where appropriate, their bronchitis and who choose the intake of Sinolpan® (forte) for therapy.
- Suitable patients for the control group are patients aged 18 years or older who seek advice from a pharmacy regarding the treatment of their acute or chronic (rhino) sinusitis and who choose to apply nasal α-sympathomimetics for therapy.
Exclusion
- According to the instructions for use
Key Trial Info
Start Date :
January 8 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT04703673
Start Date
January 8 2021
End Date
April 30 2022
Last Update
October 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ClinCompetence Cologne GmbH
Cologne, Germany